Prospective comparison of the therapeutic effect of teriparatide with that of combined vertebroplasty with antiresorptive agents for the treatment of new-onset adjacent vertebral compression fracture after percutaneous vertebroplasty

SUMMARY: Most post-vertebroplasty new-onset adjacent vertebral compression fractures (VCFs) occur within 2–3 months, and antiresorptive agents do not significantly reduce the risk of their occurrence. In opposite mechanism, teriparatide directly stimulates bone formation and improves bone strength a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Y.-Y., Su, C.-H., Lui, T.-N., Yeh, Y.-S., Yeh, S.-H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332357/
https://www.ncbi.nlm.nih.gov/pubmed/21769661
http://dx.doi.org/10.1007/s00198-011-1730-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332357/
https://www.ncbi.nlm.nih.gov/pubmed/21769661
http://dx.doi.org/10.1007/s00198-011-1730-y

Ejemplares similares